ATEM Capital
New York City, New Yorkatemcap.com
Overview
ATEM Capital is a New York-based venture capital firm founded in 2014 that specializes in early, late-stage, and growth capital investments within the life sciences sector . The firm primarily targets the biotechnology and pharmaceuticals fields, allocating 70% of its investments to these areas, which includes a focus on early-stage and late-stage assets. Additionally, it invests in de-risked medical devices and diagnostics, accounting for the remaining 30% of its portfolio . ATEM Capital is particularly interested in life-saving and life-changing technologies, including those related to oncology, cardiovascular health, anti-infectives, CNS/pain management, and women's health .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Arpeggio | Sep 2022 | Series A | Co-investor |
| Triumvira Immunologics | Mar 2022 | Series A Extension | - |
| Iridia, Inc. | Mar 2021 | Series B | Co-investor |
| Walden | Oct 2020 | Series A | - |
| Epic Sciences | Sep 2018 | Series E | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
